The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis. Binquet C, Lejeune C, Seror V, Peyron F, et al. PLoS One 2019;14:e0221709.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Binquet C, Lejeune C, Seror V, Peyron F, et al. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis. PLoS One 2019;14:e0221709.
PMID: 31532766